TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes. (Q39455092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

TLR7/8 ligand, R-848, inhibits IgE synthesis by acting directly on B lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

E Shen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

C Wu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

4 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

560-568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18397197%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of the hygiene hypothesis--molecular and otherwise

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

The immune response modifier resiquimod mimics CD40-induced B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Allergy and allergic diseases. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

The role of immunoglobulin E in allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Negative feedback regulation of IgE synthesis by murine CD23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Divide and conquer: the importance of cell division in regulating B-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Toll-like receptor stimulation as a third signal required for activation of human naive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X

Control of B-cell responses by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2008.02105.X